Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,220,917 papers from all fields of science
Search
Sign In
Create Free Account
Replication Licensing
A process that limits duplication of the genome to once per cell division cycle. In eukaryotes replication origins are limited to a single initiation…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
22 relations
CDC6 protein, human
CDT1 Gene
CDT1 wt Allele
DNA Replication
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
The Geminin and Idas Coiled Coils Preferentially Form a Heterodimer That Inhibits Geminin Function in DNA Replication Licensing*
C. Caillat
,
Dafni-Eleftheria Pefani
,
+4 authors
A. Perrakis
Journal of Biological Chemistry
2013
Corpus ID: 7889564
Background: Idas is a homologue of the proliferation and differentiation regulator, Geminin. Results: Idas and Geminin form…
Expand
2010
2010
Activation of Cdk2/Cyclin E complexes is dependent on the origin of replication licensing factor Cdc6 in mammalian cells
Cara L. Lunn
,
J. Chrivia
,
J. Baldassare
Cell Cycle
2010
Corpus ID: 21772033
Cyclin E-associated CDK2 activity is required for the initiation of DNA synthesis in human cells. CDK2 activity is tightly…
Expand
2009
2009
Redundant and differential regulation of multiple licensing factors ensures prevention of re-replication in normal human cells
Nozomi Sugimoto
,
Kazumasa Yoshida
,
+5 authors
M. Fujita
Journal of Cell Science
2009
Corpus ID: 2796179
When human cells enter S-phase, overlapping differential inhibitory mechanisms downregulate the replication licensing factors…
Expand
2007
2007
A novel quantitative proteomics strategy to study phosphorylation-dependent peptide-protein interactions.
Fei Zhou
,
J. Galan
,
R. Geahlen
,
W. Tao
Journal of Proteome Research
2007
Corpus ID: 7037323
Phosphorylation-dependent protein-protein interactions provide the mechanism for a large number of intracellular signal…
Expand
2004
2004
The regulation of competence to replicate in meiosis by Cdc6 is conserved during evolution
J. Lemaître
,
S. Bocquet
,
+5 authors
M. Méchali
Molecular Reproduction and Development
2004
Corpus ID: 11669804
DNA replication licensing is an important step in the cell cycle at which cells become competent for DNA replication. When the…
Expand
Highly Cited
2002
Highly Cited
2002
Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma.
J. Shohet
,
John Hicks
,
+7 authors
J. G. N. Texas
Cancer Research
2002
Corpus ID: 9035214
The MYCN oncogene is amplified in approximately 25% of neuroblastoma tumors and is the most significant negative prognostic…
Expand
Review
1997
Review
1997
The DNA replication licensing system.
Pia Thömmes
,
J. Blow
Cancer Surveys
1997
Corpus ID: 41372688
The Xenopus cell free system has proved a good model system to study in vitro DNA replication and the mechanism preventing…
Expand
Review
1996
Review
1996
Cell cycle control of replication initiation in eukaryotes.
S. Chevalier
,
J. Blow
Current Opinion in Cell Biology
1996
Corpus ID: 42128972
Review
1996
Review
1996
Coordinating DNA replication with cell division: current status of the licensing concept.
M. Botchan
Proceedings of the National Academy of Sciences…
1996
Corpus ID: 600982
The replication of the genetic material during cell doubling is regulated at three apparently distinct levels. In the eukaryote…
Expand
1995
1995
A murine replication protein accumulates temporarily in the heterochromatic regions of nuclei prior to initiation of DNA replication.
M. Starborg
,
E. Brundell
,
+4 authors
C. Höög
Journal of Cell Science
1995
Corpus ID: 25225308
We have analyzed the expression of the murine P1 gene, the mammalian homologue of the yeast MCM3 protein, during the mitotic cell…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE